E. Mudgett

Primary and metastatic breast carcinoma: initial clinical evaluation with PET with the radiolabeled glucose analogue 2-[F-18]-fluoro-2-deoxy-D-glucose.

R L Wahl, R. Wahl, R. Cody, 1991, Radiology.

Treatment of neuroblastoma with [125I]metaiodobenzylguanidine.

K. Zasadny, R. Hutchinson, J. Sisson, 1991, Journal of nuclear biology and medicine.

Positron-emission tomographic scanning of primary and metastatic breast carcinoma with the radiolabeled glucose analogue 2-deoxy-2-[18F]fluoro-D-glucose.

R. Wahl, R. Cody, G. Hutchins, 1991, The New England journal of medicine.

Iodine-125-MIBG to treat neuroblastoma: preliminary report.

R. Wahl, K. Zasadny, D. Normolle, 1990, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.

Radiopharmaceutical therapy of malignant pheochromocytoma with [131I]metaiodobenzylguanidine: results from ten years of experience.

K. Zasadny, W. Beierwaltes, J. Sisson, 1991, Journal of nuclear biology and medicine.

Imaging, dosimetry, and radioimmunotherapy with iodine 131-labeled anti-CD37 antibody in B-cell lymphoma.

M. Kaminski, R. Wahl, K. Koral, 1992, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.